- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis, Relapsing-Remitting in United Kingdom
Total 1433 results
-
Johns Hopkins UniversityWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
University of Southern CaliforniaNovartis PharmaceuticalsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Washington University School of MedicineCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jeffrey GelfandActive, not recruitingFecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis (MS-BIOME)Relapsing Remitting Multiple SclerosisUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Bristol-Myers SquibbTerminated
-
Johns Hopkins UniversityUniversity of California, San Francisco; National Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
NovartisCompletedClinically Isolated Syndrome | Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingRelapsing Remitting Multiple SclerosisChina, United States, Ukraine, Poland
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Poland, Romania, Russian Federation, South Africa, Ukraine, United Kingdom
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Terry L. WahlsActive, not recruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Nottingham Trent University; Sheffield Hospitals CharityRecruiting
-
University of NottinghamNational Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
University of Colorado, DenverCompleted
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
University of VermontCompletedFatigue | Sleep Initiation and Maintenance Disorders | Relapsing Remitting Multiple SclerosisUnited States